Francisco X Castellanos, MD Disclosures: BOL Pharma, Israel-Membership on advisory committees or review panels-scientific advisor -Cannabis-based therapies -autism spectrum disorder-Option_2-Option_1-None in this CME activity - 12/14/2020 No Bio Available.